World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
132
Citations
58301
World Ranking
2332
National Ranking
1317

Carlos A. Zarate publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlos A. Zarate sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carlos A. Zarate D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlos A. Zarate sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carlos A. Zarate is affiliated with the National Institutes of Health in the United States. Their research contributions primarily focus on neuroscience, medicine, and psychology, with a substantial number of publications addressing pharmacology, biological psychiatry, cognitive neuroscience, experimental and cognitive psychology, and cellular and molecular neuroscience.

The scientist's work covers a broad range of topics including:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Functional Brain Connectivity Studies
  • Suicide and Self-Harm Studies
  • Neuroscience and Neuropharmacology Research
  • Stress Responses and Cortisol

Carlos A. Zarate's recent notable publications include:

  • "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation," 2021, American Journal of Psychiatry
  • "Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis," 2020, Journal of Affective Disorders
  • "Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability," 2021, Molecular Psychiatry
  • "ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing," 2020, Translational Psychiatry
  • "The role of dissociation in ketamine's antidepressant effects," 2020, Nature Communications

The scientist frequently publishes in leading venues such as:

  • Biological Psychiatry
  • Journal of Affective Disorders
  • Molecular Psychiatry
  • Neuropsychopharmacology
  • Translational Psychiatry

Frequent co-authors collaborating with Carlos A. Zarate include:

  • Elizabeth D. Ballard
  • Jessica R. Gilbert
  • Bashkim Kadriu
  • Jennifer W. Evans
  • Todd D. Gould

Best Publications

  • A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche

  • NMDAR inhibition-independent antidepressant actions of ketamine metabolites

    Panos Zanos;Ruin Moaddel;Patrick J. Morris;Polymnia Georgiou

  • Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

    Sungho Maeng;Carlos A. Zarate;Jing Du;Robert J. Schloesser

  • Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

    Panos Zanos;Ruin Moaddel;Patrick J. Morris;Lace M. Riggs

  • A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression

    Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg

  • Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

    Gerard Sanacora;Carlos A. Zarate;John H. Krystal;Husseini K. Manji

  • Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

    Carlos A. Zarate;Nancy E. Brutsche;Lobna Ibrahim;Jose Franco-Chaves

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    D P Hibar;L T Westlye;L T Westlye;N T Doan;N T Doan;N Jahanshad

  • The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

    Samuel T. Wilkinson;Elizabeth D. Ballard;Michael H. Bloch;Sanjay J. Mathew

  • Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

    Husseini K Manji;Jorge A Quiroz;Jonathan Sporn;Jennifer L Payne

  • Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

    Nancy DiazGranados;Lobna A. Ibrahim;Nancy E. Brutsche;Rezvan Ameli

  • The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence

    Mauricio Tohen;Carlos A. Zarate;John Hennen;Hari Mandir Kaur Khalsa

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

    Mauricio Tohen;Terence A. Ketter;Carlos A. Zarate;Trisha Suppes

  • A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression

    Carlos A. Zarate;Jaskaran B. Singh;Jorge A. Quiroz;Georgette De Jesus

  • Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.

    Mauricio Tohen;K N Roy Chengappa;Trisha Suppes;Robert W Baker

  • International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.

    Ayal Schaffer;Erkki T. Isometsä;Leonardo Tondo;Doris H Moreno

  • Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

    Carlos A Zarate;Jennifer L Payne;Jaskaran Singh;Jorge A Quiroz

Frequent Co-Authors

Rodrigo Machado-Vieira
Rodrigo Machado-Vieira The University of Texas Health Science Center at Houston
David A. Luckenbaugh
David A. Luckenbaugh National Institutes of Health
Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Husseini K. Manji
Husseini K. Manji National Institutes of Health
Wayne C. Drevets
Wayne C. Drevets Johnson & Johnson (United States)
Mark J. Niciu
Mark J. Niciu University of Iowa
Todd D. Gould
Todd D. Gould University of Maryland, Baltimore
Mauricio Tohen
Mauricio Tohen University of New Mexico
Maura L. Furey
Maura L. Furey Janssen (Belgium)
Ruin Moaddel
Ruin Moaddel National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Medicine can open diverse career options in healthcare. Many students interested in leadership roles choose cahme accredited mha online programs. These programs allow you to study health administration and management from anywhere, providing flexibility for busy schedules.

For nurses looking to advance without stepping away from work, online RN to BSN degrees offer a solution. Some top rn to bsn no clinical hours programs eliminate the need for traditional clinical experiences, making them accessible to working professionals.

If you’re aiming for advanced practice or leadership in nursing, consider Doctor of Nursing Practice (DNP) programs. The accelerated dnp programs let you earn your degree faster, so you can move quickly into higher clinical or organizational roles. Budget is often a concern, but there are cheapest dnp programs available online that balance cost, speed, and academic credibility.

Exploring these online pathways helps you tailor your education to your career goals, while balancing work and family commitments.

Best Scientists Citing Carlos A. Zarate

Trending Scientists

Recently Published Articles